Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
A 5‐decade analysis of 13,715 carcinoid tumors
TLDR
Traces of Human Migrations in Helicobacter pylori Populations
- D. Falush, T. Wirth, S. Suerbaum
- GeographyScience
- 7 March 2003
Helicobacter pylori, a chronic gastric pathogen of human beings, can be divided into seven populations and subpopulations with distinct geographical distributions. These modern populations derive…
The epidemiology of gastroenteropancreatic neuroendocrine tumors.
- B. Lawrence, B. Gustafsson, A. Chan, B. Svejda, M. Kidd, I. Modlin
- MedicineEndocrinology and metabolism clinics of North…
- 1 March 2011
Current status of gastrointestinal carcinoids.
- I. Modlin, M. Kidd, I. Latich, M. Zikusoka, M. Shapiro
- MedicineGastroenterology
- 1 May 2005
TLDR
Bronchopulmonary neuroendocrine tumors
- B. Gustafsson, M. Kidd, A. Chan, M. Malfertheiner, I. Modlin
- MedicineCancer
- 1 July 2008
TLDR
Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease
- I. Modlin, B. Gustafsson, S. Moss, M. Pavel, A. Tsolakis, M. Kidd
- Medicine, BiologyAnnals of Surgical Oncology
- 9 March 2010
TLDR
Neuroendocrine tumor epidemiology
- O. Hauso, B. Gustafsson, I. Modlin
- MedicineCancer
- 15 November 2008
The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program has proven to be a significant resource in US neuroendocrine tumor (NET) epidemiology. Norway also holds a…
Pathology Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathology Data Set
- D. Klimstra, I. Modlin, James C Yao
- MedicineThe American journal of surgical pathology
- 1 March 2010
TLDR
Recommendations for management of patients with neuroendocrine liver metastases.
- A. Frilling, I. Modlin, R. Schilsky
- MedicineThe Lancet. Oncology
- 2014
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
TLDR
...
...